[Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
作者信息
Lacour J, Lacour F, Spira A, Michelson M, Petit J Y, Delage G, Sarrazin D, Contesso G, Viguier J
出版信息
Chirurgie. 1984;110(4):418-24.
PMID:6389040
Abstract
摘要
相似文献
1
2
3
[Trials of (poly A. poly U) adjuvant immunotherapy in breast cancer treatment].
Bull Cancer. 1974 Apr-Jun;61(2):275-80.
4
Clinical trials using polyadenylic-polyuridylic acid as an adjuvant to surgery in treating different human tumors.
J Biol Response Mod. 1985 Oct;4(5):538-43.
5
Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.
Eur J Surg Oncol. 1988 Aug;14(4):311-6.
6
[Therapeutic trial of Poly(A).Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results].
Chirurgie. 1988;114(6):516-23.
7
Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.
Br Med J (Clin Res Ed). 1984 Feb 25;288(6417):589-92. doi: 10.1136/bmj.288.6417.589.
8
A new adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer.
Recent Results Cancer Res. 1982;80:200-6. doi: 10.1007/978-3-642-81685-7_32.
9
A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.
J Biol Response Mod. 1985 Apr;4(2):129-33.
10
Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer: a 14 year follow-up analysis of a randomized trial of the Fédération Nationale des Centres de Lutte contre le Cancer (FNCLCC).
Breast Cancer Res Treat. 2000 Nov;64(2):189-91. doi: 10.1023/a:1006498121628.
Zotero 插件